Related Experiment Video
Updated: Jul 6, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Use of enoxaparin in patients undergoing percutaneous coronary intervention
Rajan A Kadakia1, James J Ferguson
1St. Luke's Episcopal Hospital, Texas Heart Institute, Baylor College of Medicine, Houston, Texas 77225, USA.
Insights
Enoxaparin shows improved outcomes in acute coronary syndromes, but managing patients needing coronary intervention requires specific strategies. This study outlines four approaches for enoxaparin transition to the catheterization lab.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Enoxaparin use is supported by large trials for acute coronary syndromes.
- Guidelines now include enoxaparin for unstable angina/non-ST elevation myocardial infarction.
- Managing patients on enoxaparin before coronary intervention presents challenges.
Purpose of the Study:
- To present management strategies for patients on subcutaneous enoxaparin undergoing coronary intervention.
- To provide specific enoxaparin dosing recommendations in this setting.
Main Methods:
- Review of clinical trial evidence.
- Development of four distinct management strategies.
- Formulation of dosing recommendations for catheterization laboratory transition.
Main Results:
- Four potential management strategies are detailed.
- Specific enoxaparin dosing guidelines are proposed for procedural management.
Conclusions:
- Effective management strategies are crucial for patients on enoxaparin requiring coronary intervention.
- Standardized dosing recommendations can optimize care during transition to the catheterization lab.
Abstract:
Recent large-scale trials have demonstrated superior clinical outcomes associated with the use of enoxaparin in patients with acute coronary syndromes and have led to its incorporation into the recent American College of Cardiology/American Heart Association guidelines for the management of patients with unstable angina/non-ST elevation myocardial infarction. Despite clinical trial evidence, questions arise as to how best to manage patients who have received subcutaneous enoxaparin who may then require subsequent coronary intervention. We present four potential management strategies for handling the transition of these patients to the catheterization laboratory and specific dosing recommendations for the use of enoxaparin in these circumstances.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Cardiac Catheterization IV: Nursing Management
